Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc add-on to cART in late-diagnosed advanced HIV-1 infection
2010-022293-14Phase 4Completed
- Sponsor
- Inserm-ANRS
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aprepitant in Human immunodeficiency virus infection type 1 (2 arms), sponsored by Inserm-ANRS. Primary endpoint: New AIDS-defining event. Started Jul 2012; status: completed.
02
Drugs
aprepitant
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2010-022293-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022293-14.